Company description

Bedrocan is the world’s most experienced producer of natural API medicinal cannabis. We are currently the only company producing medicinal cannabis raw material to good manufacturing practice (GMP) standards. Bedrocan’s products are fully standardised. This means each product contains a constant composition of cannabinoids and terpenes. In cooperation with trusted partners Bedrocan also produces isolated compounds and extractions on demand: THC (Tetrahydrocannabinol), CBD (Cannabidiol) and CBG (Cannabigerol). Bedrocan also offers scientific and clinical research expertise to the pharmaceutical industry at all stages of product development, from formulation development to administration forms and clinical study design. The quality of our processes and our emphasis on scientific expertise to support medicine development reflects our vision to develop and deliver the full medical potential of cannabis to those in need worldwide. Our mission is to be a bridge between patients’ needs for cannabis and the quality standards of modern medicine.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Other APIs |Plant Extracts |APIs More

Upcoming events

13 oct 2020

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 16A73 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 41B46 See our Exhibitor Profile   See full Exhibitor List

News about Bedrocan

Vaping vs vaporization

11 Oct 2019

Vaping vs vaporization

There has been a lot of talk in the media about the risks of vaping. This article discusses the differences between vaping and the administering cannabis flos by vaporization. In the United States the vaping phenomenon hit the headlines this year after the American Centre for Disease Control and Prevention (CDC) reported at least eighteen fatalities and more than 1,000 people with serious lung complaints after vaping. 

Read more

1 Jul 2019

Bedrocan discusses standardised pharmaceutical quality medicinal cannabis

A global trend has arisen: Prescribers are becoming more familiar with cannabis-based medicines and prescribing them. The increasing demand for pharmaceutical quality cannabis-based medicines has resulted in greater need for reliable, consistent active pharmaceutical ingredient (API).

Read more

24 Jun 2019

‘Cannabis-oil quality should be beyond dispute’

Infinity Pharma in Helmond, the Netherlands, is a pharmacy that works with regular medication as well as ‘new’ medicinal products, such as cannabis oil.

Read more

24 Jun 2019

This inhaler will increase the acceptance of cannabis as medicine

It took him seven years and tens of millions of dollars to transform a raw plant into a mainstream medical drug. Perry Davidson is the creator of the Syqe Inhaler – a new technology that allows doctors and patients to precisely dose pharmaceutical quality ‘cannabis flos’ by inhalation.

Read more

Categories affiliated with Bedrocan


Contact information




View all contact information